← Leaderboards
Jason M. Held
Washington University
$4,288,297
Attributed
$4,832,968
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $849K · FY2009–24$1M$750K$500K$250K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$4,832,968 · 6
By mechanism
R21$2,697,469 · 5
R01$2,135,499 · 1
Top collaborators
- Vladimir B Birman3 shared
- Kerry Kornfeld3 shared
Most similar at Washington University
Same institution · by research overlap
- Haowei Song$157,044
- Nathan Ravi$1,093,776
- Kerry Kornfeld$13,611,393
- Ramki Kalyanaraman$3,767,148
- Manel Errando$2,649,505
Others in their field
Top investigators on “Signal Transduction”
- Peter B. Gilbert · Fred Hutchinson Cancer Center$148,539,615
- David Heimbrook · Leidos Biomedical Research, Inc.$82,049,940
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$70,290,471
- Garret A Fitzgerald · University Of Pennsylvania$66,142,222
- Michael Barry Kastan · Duke University$64,512,357
- Randall J Bateman · Washington University$62,939,456
Research focus
Signal TransductionProteinsRegulationCysteinePlayNeoplasm MetastasisOxidation-ReductionMalignant NeoplasmsIn VivoOxidationComplexMolecularCellsProductionTechnologyReactive Oxygen SpeciesResponseOverexpressionCancer CellBaseEnzymesCancer BiologyChemistryPhenotype
Grant awards (19)
Investigating GSTP1 as a novel regulator of the cysteine redoxome in breast cancer and maker of vulnerability to redox-based therapy$207,185
R21 · FY2024 · CA · contact PI
Investigating GSTP1 as a novel regulator of the cysteine redoxome in breast cancer and maker of vulnerability to redox-based therapy$183,104
R21 · FY2023 · CA · contact PI
INVESTIGATING NAPDH OXIDASES AND REDOX SIGNALING IN LUNG CANCER TUMORIGENICITY$554,382
R01 · FY2020 · CA · contact PI
Supplement: USING OPTOGENETICS TO DISSECT THE ROLE OF REDOX SIGNALING DURING C. ELEGANS AGING$50,000
R21 · FY2020 · AG · contact PI
INVESTIGATING NAPDH OXIDASES AND REDOX SIGNALING IN LUNG CANCER TUMORIGENICITY$338,378
R01 · FY2019 · CA · contact PI
INVESTIGATING NAPDH OXIDASES AND REDOX SIGNALING IN LUNG CANCER TUMORIGENICITY$196,207
R01 · FY2019 · CA · contact PI
Using Optogenetics to Dissect the Role of Redox Signaling During C. Elegans Aging$196,093
R21 · FY2019 · AG · contact PI
INVESTIGATING NAPDH OXIDASES AND REDOX SIGNALING IN LUNG CANCER TUMORIGENICITY$348,844
R01 · FY2018 · CA · contact PI
DEVELOPMENT OF NOVEL CHEMICAL PROBES TO MAP S-NITROSYLATION IN CANCER$266,875
R21 · FY2018 · CA · contact PI
Using Optogenetics to Dissect the Role of Redox Signaling During C. Elegans Aging$233,250
R21 · FY2018 · AG · contact PI
INVESTIGATING NAPDH OXIDASES AND REDOX SIGNALING IN LUNG CANCER TUMORIGENICITY$348,844
R01 · FY2017 · CA · contact PI
DEVELOPMENT OF NOVEL CHEMICAL PROBES TO MAP S-NITROSYLATION IN CANCER$190,625
R21 · FY2017 · CA · contact PI
INVESTIGATING NAPDH OXIDASES AND REDOX SIGNALING IN LUNG CANCER TUMORIGENICITY$348,844
R01 · FY2016 · CA · contact PI
DEVELOPMENT OF NOVEL CHEMICAL PROBES TO MAP S-NITROSYLATION IN CANCER$152,500
R21 · FY2016 · CA · contact PI
The role of p53 redox-modification in cell fate signaling$168,441
R21 · FY2014 · CA · contact PI
The role of p53 redox-modification in cell fate signaling$204,759
R21 · FY2013 · CA · contact PI
OxMRM: A Technique to Quantify Oxidation of Endogenous Redox-Sensitive Cysteines$289,797
R21 · FY2011 · CA · contact PI
OxMRM: A Technique to Quantify Oxidation of Endogenous Redox-Sensitive Cysteines$298,760
R21 · FY2010 · CA · contact PI
OxMRM: A Technique to Quantify Oxidation of Endogenous Redox-Sensitive Cysteines$256,080
R21 · FY2009 · CA · contact PI